Biotech Investors & VC Firms in Singapore

25 firms in this list, with a median first check of $652K. 3 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AC AC Ventures ALMSPSHW30 people · Follows rounds	88🔒	Jakarta	ID	Seed–Growth	$963K – $87M	+ Add to CRM
WA Wavemaker Partners AHBJEMPS27 people · Leads rounds	88🔒	Singapore	SG	Pre-Seed–Growth	$880K – $20M	+ Add to CRM
CL ClavystBio FAKSKLAT33 people	88🔒	Singapore	SG	Seed–Series A	—	+ Add to CRM
K3 K3 Ventures KMSLTTYJ23 people	88🔒	Singapore	SG	Seed–Growth	$1.2M – $42M	+ Add to CRM
PA Panacea Venture JHAAANAC20 people	88🔒	Singapore	SG	Pre-Seed–Late Stage	—	+ Add to CRM
SG SGInnovate DLHTMHMJ27 people	88🔒	Singapore	SG	Seed–Series A	$652K – $18M	+ Add to CRM
IN Incubate Fund MHNMDKRR12 people · Leads rounds	88🔒	Tokyo	JP	Pre-Seed–Seed	—	+ Add to CRM
EX Expara KALDM(PA17 people	88🔒	Singapore	SG	Pre-Seed–Series A	$320K – $600K	+ Add to CRM
VE Vertex Ventures China CCJYTLWL6 people · Follows rounds	88🔒	Singapore	SG	Pre-Seed–Late Stage	$2M – $85M	+ Add to CRM
VE Vertex Venture Management Pte. Ltd. CKCSJCCS16 people	88🔒	Singapore	SG	Pre-Seed–Growth	—	+ Add to CRM
DE Decacorn Capital DAAA12 people	88🔒	Singapore	SG	Seed–Series B	$300K – $600K	+ Add to CRM
NS NSG Ventures DTJLTLKN9 people	88🔒	Singapore	SG	Seed–Series A	—	+ Add to CRM
BL BlueOcean Ventures EDFSSHTZ6 people · Leads rounds	88🔒	Geneva	CH	Pre-Seed–Series A	$270K – $1.4M	+ Add to CRM
ED EDB Investments CKCLCGJO11 people	88🔒	Singapore	SG	Seed–Late Stage	$12M – $400M	+ Add to CRM
VE Vertex Ventures HC CBLHYLAC6 people	88🔒	Singapore	SG	Seed–Growth	$500K – $10M	+ Add to CRM
FR Frontline Strategy Funds AKVA2 people	88🔒	Singapore	SG	Seed–Growth	$5M – $15M	+ Add to CRM
MP MPCi (formerly Matrix Partners China) BSDSDZEY11 people	88🔒	Singapore	CN	Seed–Growth	—	+ Add to CRM
SE SEEDS Capital Follows rounds	88🔒	Singapore	SG	Pre-Seed–Series B	$250K – $9M	+ Add to CRM
TR Trinity Innovation Bioventure Singapore TKJZDX3 people · Follows rounds	88🔒	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
MA Majuven LHLTLYHK4 people	88🔒	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
HO Hotung Investment Holdings Ltd.	88🔒	Singapore	SG	Series A–Late Stage	$300K – $1.5M	+ Add to CRM
LA Lanchi Ventures JT1 person · Follows rounds	88🔒	Singapore	SG	Pre-Seed–Series A	—	+ Add to CRM
EV Everlife AO1 person	88🔒	Singapore	SG	—	—	+ Add to CRM
CB CBC Group XG1 person	88🔒	Singapore	SG	Seed–Late Stage	—	+ Add to CRM

AC Ventures

JakartaSeed–Growth$963K – $87M

ALMSPSHW30 people

Wavemaker Partners

SingaporePre-Seed–Growth$880K – $20M

AHBJEMPS27 people

ClavystBio

SingaporeSeed–Series A

FAKSKLAT33 people

K3 Ventures

SingaporeSeed–Growth$1.2M – $42M

KMSLTTYJ23 people

Panacea Venture

SingaporePre-Seed–Late Stage

JHAAANAC20 people

SGInnovate

SingaporeSeed–Series A$652K – $18M

DLHTMHMJ27 people

Incubate Fund

TokyoPre-Seed–Seed

MHNMDKRR12 people

Expara

SingaporePre-Seed–Series A$320K – $600K

KALDM(PA17 people

Vertex Ventures China

SingaporePre-Seed–Late Stage$2M – $85M

CCJYTLWL6 people

Vertex Venture Management Pte. Ltd.

SingaporePre-Seed–Growth

CKCSJCCS16 people

Decacorn Capital

SingaporeSeed–Series B$300K – $600K

DAAA12 people

NSG Ventures

SingaporeSeed–Series A

DTJLTLKN9 people

BlueOcean Ventures

GenevaPre-Seed–Series A$270K – $1.4M

EDFSSHTZ6 people

EDB Investments

SingaporeSeed–Late Stage$12M – $400M

CKCLCGJO11 people

Vertex Ventures HC

SingaporeSeed–Growth$500K – $10M

CBLHYLAC6 people

Frontline Strategy Funds

SingaporeSeed–Growth$5M – $15M

AKVA2 people

MPCi (formerly Matrix Partners China)

SingaporeSeed–Growth

BSDSDZEY11 people

SEEDS Capital

SingaporePre-Seed–Series B$250K – $9M

Trinity Innovation Bioventure Singapore

SingaporeSeed–Late Stage

TKJZDX3 people

Majuven

SingaporeSeed–Late Stage

LHLTLYHK4 people

Hotung Investment Holdings Ltd.

SingaporeSeries A–Late Stage$300K – $1.5M

Lanchi Ventures

SingaporePre-Seed–Series A

JT1 person

Everlife

Singapore

AO1 person

CBC Group

SingaporeSeed–Late Stage

XG1 person

Data sourced from public filings and firms' own websites — see our methodology.